Gene · 1105
Papers1,932
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,932
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features. | Nat Commun | 2022 | 35817764 | PubTator, text mining | PubMed |
| PTEN: An Emerging Potential Target for Therapeutic Intervention in Respiratory Diseases. | Oxid Med Cell Longev | 2022 | 35814272 | PubTator, text mining | PubMed |
| Global Trends of Stem Cell Precision Medicine Research (2018-2022): A Bibliometric Analysis. | Front Surg | 2022 | 35813047 | PubTator, text mining | PubMed |
| Transcriptomic and Functional Evidence for Differential Effects of MCF-7 Breast Cancer Cell-Secretome on Vascular and Lymphatic Endothelial Cell Growth. | Int J Mol Sci | 2022 | 35806196 | PubTator, text mining | PubMed |
| Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironment. | J Transl Med | 2022 | 35794606 | PubTator, text mining | PubMed |
| Integrated analysis of genes encoding ATP-dependent chromatin remodellers identifies CHD7 as a potential target for colorectal cancer therapy. | Clin Transl Med | 2022 | 35789070 | PubTator, text mining | PubMed |
| Evaluation of post-operative surveillance strategies for esophageal and gastric cancers: a systematic review and meta-analysis. | Dis Esophagus | 2022 | 35788834 | PubTator, text mining | PubMed |
| Role of ATP-dependent chromatin remodelers in hematopoietic stem and progenitor cell maintenance. | Curr Opin Hematol | 2022 | 35787545 | PubTator, text mining | PubMed |
| CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2. | Cancer Res | 2022 | 35771632 | PubTator, text mining | PubMed |
| Biomineralization associated alkaline phosphatase as a potential marker of bone metastasis in the patients with invasive breast cancer. | Saudi J Biol Sci | 2022 | 35770272 | PubTator, text mining | PubMed |
| Targeting signaling pathways in prostate cancer: mechanisms and clinical trials. | Signal Transduct Target Ther | 2022 | 35750683 | PubTator, text mining | PubMed |
| The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancer. | NPJ Precis Oncol | 2022 | 35715489 | PubTator, text mining | PubMed |
| Structural basis of nucleosome retention during transcription elongation. | Science | 2022 | 35709268 | PubTator, text mining | PubMed |
| Evaluation of NOTCH family genes' expression and prognostic value in prostate cancer. | Transl Androl Urol | 2022 | 35693717 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Deregulated molecules and pathways in the predisposition and dissemination of breast cancer cells to bone. | Comput Struct Biotechnol J | 2022 | 35685372 | PubTator, text mining | PubMed |
| From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer. | Int J Mol Sci | 2022 | 35682963 | PubTator, text mining | PubMed |
| Virtual ChIP-seq: predicting transcription factor binding by learning from the transcriptome. | Genome Biol | 2022 | 35681170 | PubTator, text mining | PubMed |
| Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer. | Front Oncol | 2022 | 35669415 | PubTator, text mining | PubMed |
| Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay. | NAR Cancer | 2022 | 35664542 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1105/papers?page=20